All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C6H6BrNO2S
CAS Number:
Molecular Weight:
236.09
Beilstein:
2691657
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Recommended Products
Assay
≥99.0% (T)
form
solid
SMILES string
NS(=O)(=O)c1ccc(Br)cc1
InChI
1S/C6H6BrNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10)
InChI key
STYQHICBPYRHQK-UHFFFAOYSA-N
General description
4-Bromobenzenesulfonamide is a metabolite of ebrotidine, a new H2-receptor antagonist.
Application
4-Bromobenzenesulfonamide was used as reagent in preparation of cobalt(III) complexes of N,R-sulfonyldithiocarbimate anion. It was also used in the synthesis of 2-, 3- and 4-(substituted-phenylethynyl)benzenesulfonamides.
Signal Word
Warning
Hazard Statements
Hazard Classifications
Acute Tox. 4 Oral
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Preparation of novel cobalt (III) complexes with dithiocarbimates derived from sulfonamides.
Oliveira MRL and Bellis VMD.
Transition Metal Chemistry, 24(2), 127-130 (1999)
Raymond Anana et al.
Bioorganic & medicinal chemistry, 14(15), 5259-5265 (2006-04-26)
A group of regioisomeric phenylethynylbenzenesulfonamides possessing a COX-2 SO2NH2 pharmacophore at the para-, meta- or ortho-position of the C-1 phenyl ring, in conjunction with a C-2 substituted-phenyl (H, OMe, OH, Me, F) group, were synthesized and evaluated as inhibitors of
E Rozman et al.
Journal of pharmaceutical sciences, 83(2), 252-254 (1994-02-01)
Ebrotidine is a new H2-receptor antagonist which exhibits a remarkable ability for gastric mucosal protection. A preliminary metabolic pathway for this compound was proposed and the hypothetic metabolites were synthesized. The presence of ebrotidine and its metabolites ebrotidine S-oxide and
Gloria Uccello-Barretta et al.
Bioorganic & medicinal chemistry, 12(2), 447-458 (2004-01-16)
NMR spectroscopic and molecular modelling methods have been employed to describe the complexation of trans-N-4-[N'-(4-chlorobenzoyl)hydrazinocarbonyl]cyclohexylmethyl-4-bromobenzenesulfonamide, a new chemotype of NPY-5 antagonist, and beta-cyclodextrin, revealing the coexistence of two different kinds of 1:1 complexes where conformational changes of the guest compound
S Sentellas et al.
Electrophoresis, 22(1), 71-76 (2001-02-24)
This paper illustrates the possibilities of chemometric methods in the resolution and quantification of various compounds in overlapping peaks from capillary electrophoresis. Ebrotidine and most of its metabolites were efficiently separated by capillary zone electrophoresis (CZE) in a fused-silica capillary.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service